Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guideline Platform
  3. Gynaecology
  4. Back
  5. Gynaecology guidelines
  6. Minimising urinary tract injury at gynaecological surgery for benign disease (1038)
Announcements and latest updates

Right Decision Service newsletter: April 2024

Welcome to the Right Decision Service (RDS) newsletter for April 2024. 

Issues with RDS and Umbraco access

Tactuum has been working hard to address the issues experienced during the last week. They have identified a series of three mitigation measures and put the first of these in place on Friday 3rd May.  If this does not resolve the problems, the second mitigation will be actioned, and then the third if necessary.

Please keep a lookout for any slowing down of the system or getting locked out. Please email myself, mbuchner@tactuum.com and onivarova@tactuum.com if you experience any problems, and also please raise an urgent support ticket via the Support Portal.

Thank you for your patience and understanding while we achieve a full resolution.

Promotion and communication resources

A rotating carousel presenting some of the key RDS tools and capabilities, and an editable slideset, are now available in the Resources for RDS providers section of the Learning and Support toolkit.

Redesign and improvements to RDS

The redesign of RDS Search and Browse is still on-track for delivery by mid-June 2024. We then plan to have a 3-week user acceptance testing phase before release to live. All editors and toolkit owners on this mailing list will be invited to participate in the UAT.

The archiving and version control functionality is also progressing well and we will advise on timescales for user acceptance testing shortly.

Tactuum is also progressing with the deep linking to individual toolkits within the mobile RDS app. There are several unknowns around the time and effort required for this work, which will only become clear as the work progresses. So we need to be careful to protect budget for this purpose.

New feature requests

These have all been compiled and effort estimated. Once the redesign work is complete, these will be prioritised in line with the remaining budget. We expect this to take place around late June.

Evaluation

Many thanks to those of you completed the value and impact survey we distributed in February. Here are some key findings from the 65 responses we received.

Figure 1: Impact of RDS on direct delivery of care

Key figures

  • 93% say that RDS has improved evidence-informed practice (high impact 62%; some impact 31%)
  • 91% report that RDS has improved consistency in practice (high impact 65%, some impact 26%)
  • 85% say that RDS has improved patient safety (high impact 59%, some impact 26%)
  • Although shared decision-making tools are only a recent addition to RDS, and only represent a small proportion of the current toolset, 85% of respondents still said that RDS had delivered impact in this area (53% high impact, 32% some impact.) 92% anticipate that RDS will deliver impact on shared decision-making in future and 85% believe it will improve delivery of personalised care in future.

Figure 2 shows RDS impact to date on delivery of health and care services

 

Key figures

These data show how RDS is already contributing to NHS reform priorities and supporting delivery of more sustainable care.

Saving time and money

  • RDS clearly has a strong impact on saving practitioner time, with 90% of respondents reporting that this is the case. 65% say it has a high impact; 25% say it has some impact on time-saving.
  • It supports devolved decision-making across the multi-professional team (85% of respondents)
  • 76% of respondents confirm that it saves money compared, for example, to investing in commercial apps (54% high impact; 22% some impact.)
  • 72% believe it has impacted already on saving money and reducing waste in the way services are delivered – e.g. reducing costs of referral management, prescribing, admissions.

Quality assurance and governance

  • RDS leads are clear that RDS has improved local governance of guidelines, with 87% confirming that this is the case. (62% high impact; 25% some impact.)

Service innovation and workforce development

  • RDS is a major driver for service innovation and improvement (83% of respondents) and has impacted significantly on workforce knowledge and skills (92% of respondents – 66% high impact; 26% some impact).

New toolkits

A few examples of toolkits published to live in the last month:

Toolkits in development

Some of the toolkits the RDS team is currently working on:

  • SARCS (Sexual Assault Response Coordination Service)
  • Staffing method framework – Care Inspectorate.
  • SIGN 171 - Diabetes in pregnancy
  • SIGN 158 – British Guideline on Management of Asthma. Selected sections will be incorporated into the RDS, and complemented by a new chronic asthma pathway being developed by SIGN, British Thoracic Society and NICE.
  • Clinical pathways from NHS Fife and NHS Lanarkshire

Please contact his.decisionsupport@nhs.scot if you would like to learn more about a toolkit. The RDS team will put you in touch with the relevant toolkit lead.

Quality audit of RDS toolkits

Thanks to all of you who have responded to the retrospective quality audit survey and to the follow up questions.  We still have some following up to do, and to work with owners of a further 23 toolkits to complete responses. An interim report is being presented to the HIS Quality and Performance Committee.

Implementation projects

Eight clinical services and two public library services are undertaking tests of change to implement the Being a partner in my care app. This app aims to support patients and the public to become active participants in Realistic Medicine. It has a strong focus on personalised, person-centred care and a library of shared decision aids, as well as simple explanations and videoclips to help the public to understand the aims of Realistic Medicine.  The tests of change will inform guidance and an implementation model around wider adoption and spread of the app.

With kind regards

Right Decision Service team

Healthcare Improvement Scotland

Minimising urinary tract injury at gynaecological surgery for benign disease (1038)

Warning

Objectives

To provide guidance for those undertaking benign gynaecological procedures where there is a risk of urinary tract injury.

Scope

All healthcare professionals undertaking gynaecological procedures where there is a risk of urinary tract injury

Please report any inaccuracies or issues with this guideline using our online form

Background and rates of injury

Injury to the urinary tract at benign gynaecological surgery is uncommon as defined by the RCOG (1).

A systematic analysis found the rate of urinary tract injury in laparoscopic surgery for benign  gynaecological operations to be 3.3/1000.

Urinary tract injury is however more common at hysterectomy. RCOG consent advice (3) recommends quoting a rate of urinary tract injury of 7/1000 for abdominal hysterectomy procedures.

A retrospective study of almost 1000 hysterectomies for benign conditions in NHSGGC found the following rates of urinary tract injury (presented at ESGE 2018)

Rate of injury to bladderRate of injury to uterer
Laparoscopic hysterectomy1.3%1.9%
LAVH1%3%
Open hysterectomy0.8%0.6%

A retrospective analysis performed by the BSGE found a ureteric injury rate of 0.5% in excision of deep infiltrating endometriosis at endometriosis centres in the UK with 9.2% of procedures requiring stent insertion. (4)

Bladder injury is typically by incision of the bladder and is usually recognised at operation. Ureteric injury can occur by angulation, crushing, resection, division or damage by heat or devascularisation and may be less likely to be unrecognised (5). Ureteric injury may present late with urinary leakage being delayed after thermal or vascular damage with no apparent injury at the time of operation.

Pre-operative considerations

Alternatives to surgery should be discussed with each patient who is considering surgery.

The consent process should note any factors that may increase the rate of urological tract injury and this should be explicit in the consent process, such as but not exclusively:

Patient factors: BMI, previous pelvic surgery, previous caesarean section.

Pathology factors: pelvic abscess or endometriosis, malignancy, known hydronephrosis.

Pre-operative imaging to exclude hydronephrosis or hydroureter should be performed if there is disease suspected in the lateral pararectal fossa or a large pelvic mass. If hydronephrosis is confirmed on imaging then renography with MAG3 scanning should be performed to assess renal function. Pre-operative stent insertion should be considered and referral to urological colleagues made if hydronephrosis is confirmed or if disease processes involve the ureter.

Pre-operative request for urological opinion should be sought in these patients:

  1. Previous ureterolysis when operating in the lateral pararectal fossa is anticipated.
  2. Known hydronephrosis
  3. Known disease involving the ureter. Specialist urological radiology reporting may be needed in complex pathology.

Intraoperative considerations

The urinary bladder should be emptied to reduce the risk of urinary tract injury.

There is a difference in approach between gynaecologists and urologists when operating in proximity to the ureter. Gynaecologists do not use ureteric stents routinely when operating within the lateral pararectal space. It is recognised common gynaecological practice to visually identify the ureter prior to clamping and ligating pedicles (or using instruments for vessel sealing) or applying surgical heat at operation. Ureterolysis is performed by gynaecologists for up to 10cm of ureteric length without stent insertion. Surgeons should be familiar with the thermal effects of any energy device employed during surgery (6)

Ureteric stenting may reduce ureteric injury in two ways. Firstly it may help to identify the ureter if there is difficulty in visual identification. Secondly stenting may reduce ureteric injury leading to leakage when there has potentially been thermal or vascular damage to the ureter. Stenting may reduce the risk of hydronephrosis due to angulation injury. However stenting may alter the anatomy of the lateral pararectal fossa by straightening the ureter to a more medial position.

Urological colleagues are always happy to assist with stent insertion. Requests for an intraoperative urological opinion should be sought in these patients:

  1. If the ureter cannot be identified. Insertion of a temporary ureteric catheter may help a gynaecologist who is competent with their use to identify the ureter but may not protect against later ureteric leakage if there has been damage to the vascular supply to the ureter or thermal injury to it.
  2. If there is a bladder injury and the gynaecological surgeon does not have expertise to close the bladder.
  3. Any bladder injury where injury to the trigone is suspected.
  4. Any suspected ureteric injury.

Post-operative consideration

In patients who experience a urological complication of gynaecological surgery their operating gynaecology consultant should be the point of contact for urological colleagues.

A follow up appointment should be requested with the operating gynaecology surgeon via their secretary on patient discharge.

Editorial Information

Last reviewed: 14/07/2022

Next review date: 14/07/2027

Author(s): Chris Hardwick.

Version: 1

Approved By: Gynaecology Clinical Governance Group

Document Id: 1038

References

1. RCOG Clinical Governance Advice No. 7
2. Wong, Jacqueline M. K. MD; Bortoletto, Pietro MD; Tolentino, Jocelyn MD, MPH; Jung, Michael J. MD, MBA; Milad, Magdy P. MD, MS Obstetrics & Gynecology. 131(1):100-108, January 2018
3. Abdominal Hysterectomy for Benign Conditions (Consent Advice No. 4) (rcog.org.uk)
4. e018924.full.pdf (bmj.com)
5. Minas V, Gul N, Aust T, Doyle M, Rowlands D. Urinary tract injuries in laparoscopic gynaecological surgery; prevention, recognition and management. The Obstetrician & Gynaecologist 2014;16:19–28.
6. Bentham GL, Preshaw J. Review of advanced energy devices for the minimal access gynaecologist. The Obstetrician & Gynaecologist 2021;23:301–9. https://doi.org/10.1111/tog.12774